Current pharmacological therapies, including cholinesterase inhibitors (ChEIs) (e.g., donepezil, rivastigmine, galantamine) and N-methyl-D-aspartate (NMDA) receptor antagonists (e.g., memantine), offer only modest symptomatic relief without altering disease progression (Butterfield and Halliwell, 2019)
Better circulation means healthier follicles
Those without insurance coverage face a higher cost for Tirzepatide
Patients achieving goal weights may continue treatment indefinitely to maintain results, potentially at reduced doses
Ozempic, Wegovy, Mounjaro, and Zepbound pens have strict temperature requirements
13 Feb 2026 Maternal Diabetes Associated with Epilepsy in Offspring Maternal diabetes is associated with an increased epilepsy risk in offspring, a 2026 cohort study has found